Quest Diagnostics to use Cytyc's ThinPrep Pap test
This article was originally published in Clinica
Executive Summary
Quest Diagnostics has formed a multiyear agreement to supply of Cytyc's ThinPrep Pap test for cervical cancer screening. Quest will offer the test to its network of laboratories in the US from July, along with conventional Pap smears. The test has been offered by the world's largest clinical laboratory, Laboratory Corporation of America, since March.